Lyra Therapeutics Inc. (LYRA)
0.19
0.00 (0.42%)
At close: Jan 15, 2025, 3:59 PM
0.18
-3.72%
After-hours Jan 15, 2025, 04:08 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -4.16 | -1.72 | -1.34 | -4.44 | -14.91 | -19.29 |
| PS Ratio | 167.51 | 69.66 | 198.66 | n/a | n/a | 93.49 |
| PB Ratio | 2.92 | 1.18 | 1.65 | 1.31 | 32.73 | -1.09 |
| P/FCF Ratio | -4.06 | -2.18 | -1.94 | -4.27 | -17.18 | -17.42 |
| P/OCF Ratio | -4.12 | -2.19 | -2.19 | -4.63 | -17.44 | -17.52 |
| OCF/S Ratio | -40.63 | -31.83 | -90.6 | n/a | n/a | -5.34 |
| Debt / Equity Ratio | 0.30 | 0.03 | 0.04 | 0.03 | 0.45 | n/a |
| Quick Ratio | 5.35 | 6.97 | 2.63 | 15.54 | 1.94 | 12.72 |
| Current Ratio | 5.35 | 6.97 | 2.63 | 15.54 | 1.94 | 12.72 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | n/a | n/a | 0.05 |
| Interest Coverage | n/a | -107.45 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.7 | -0.68 | -1.24 | -0.3 | -2.2 | 0.06 |
| Return on Assets (ROA) | -0.44 | -0.5 | -0.77 | -0.27 | -1.08 | -0.24 |
| Return on Capital (ROIC) | -0.55 | -0.59 | -1.19 | -0.29 | -1.69 | -0.31 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 21.72% | -251.23% | n/a | n/a | 100.00% |
| Net Profit Margin | -4.02K% | -4.06K% | -14.88K% | n/a | n/a | -484.65% |
| Pretax Profit Margin | -4.02K% | -4.05K% | -15.27K% | n/a | n/a | -484.65% |
| Operating Profit Margin | -4.31K% | -4.13K% | -15.30K% | n/a | n/a | -583.52% |
| FCF Margin | -4.13K% | -3.20K% | -10.25K% | n/a | n/a | -536.74% |
| EBITDA Margin | -4.19K% | -3.96K% | -14.95K% | n/a | n/a | -576.93% |